Clinical evaluation of berberine therapy of acute coronary syndrome

CEBTACS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-10000868

Enrollment

Unknown

Registered

2010-04-22

Start date

2010-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome

Interventions

control:the normal therapy and berberine (0.5 Bid) , one month

treat:the normal therapy

Eligibility

Sex/Gender

Male

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: the documented acute coronary syndrome patients

Exclusion criteria

Exclusion criteria: 1. acute phase of inflammatory disease; 2. abnormal hepatic and renal function and acute phase of hepatitis; 3. with tumor, thyroid disease, tuberculosis and hormonotherapy; 4. valvular heart disease with hemodynamic abnormality; 5. reluctant to participate; 6. tristimania, mania and other mental maladjustment; 7. drug and alcohol abuse.

Design outcomes

Primary

Measure	Time frame
IL-2;hsCRP;serum amyloid protein A;IL-6;	—

Countries

China

Contacts

Public ContactMeng Shu

msdoctor@sohu.com+86 13916005250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026